Category Archives: Business and Investments

Latest From Business and Investments

13 Days Until BIO 2015: Moneyball: Acing the Big Pharma/Small Biotech Deal

BIO Business Networking

In just a few weeks, thousands of players in the pharma and biotech industry will converge on Philadelphia for BIO 2015 seeking knowledge, insight and, for many, the ultimate goal – new partnerships. Collaboration is often the key to success for emerging biotech companies and big pharma alike as it can open the door to new markets, influencers and revenue streams. In oncology, deals between established pharmaceutical companies and early-stage biotechs are especially relevant and Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Life Science Leader Asks: What is the Role VCs Play in Partnering with Small Biotech?

Life Science Leader

When Peter Young began planning his session proposal for this year’s BIO International Conference, the executive-in-residence with A.M. Pappas & Associates, like many submitters hoping to serve as 2015 BIO change agents, wanted to create a session worthy of your time. While I am sure you will find the session he will be moderating fascinating (Inventing Your Own Hub: Evolving Institutional Models for Translational Medicine, June 16, 3:30 PM – 4:45 PM, Room 105AB), Young, a Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO Innovation Zone Company Snapshot: Arytha Biosciences

BIO Innovation Zone

Next month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Science foundation (NSF) and the National Institutes of Health (NIH) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Morning Consult: Right-Sized Regulations, Innovation and Investor Protection

Jim Greenwood

Today, an op-ed from BIO President and CEO Jim Greenwood appeared in Morning Consult stressing the importance of investor protection by reforming eXtensible Business Reporting Language (XBRL), which is a one-size-fits-all costly reporting requirement that can harm company growth and investor returns. Congressman Robert Hurt (R-VA) introduced a bill – the Small Company Disclosure Simplification Act (H.R. 1965) – that would provide a temporary exemption from XBRL for newly public and low-revenue companies in order Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Innovation Zone Company Snapshots: ONL Therapeutics and Lipella Pharmaceuticals

BIO Innovation Zone

Next month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Institutes of Health (NIH) and the National Science foundation (NSF) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review process prior Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,